Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
28.07
-0.80 (-2.77%)
At close: Mar 9, 2026, 4:00 PM EDT
28.60
+0.53 (1.89%)
After-hours: Mar 9, 2026, 5:09 PM EDT
Rigel Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 367.02 | 17.49 | -25.09 | -58.57 | -17.91 | |
| Depreciation & Amortization | 2.42 | 2.23 | 1.24 | 1 | 1.16 | |
| Loss (Gain) From Sale of Assets | - | -0.08 | 0.27 | -0.14 | - | |
| Loss (Gain) From Sale of Investments | -1.15 | -0.71 | -0.48 | -0.06 | 0.29 | |
| Stock-Based Compensation | 12.71 | 12.39 | 8.81 | 12.39 | 9.49 | |
| Other Operating Activities | -285.83 | - | - | 0.68 | 3.14 | |
| Change in Accounts Receivable | -10.15 | -11.07 | 9.77 | -24.85 | 0.5 | |
| Change in Inventory | -5.64 | 0.76 | 1.17 | -2.38 | -4.88 | |
| Change in Accounts Payable | 3.85 | -3.8 | -0.37 | 3.79 | 0.04 | |
| Change in Unearned Revenue | - | - | - | -1.23 | -0.42 | |
| Change in Other Net Operating Assets | -7.58 | 14.26 | -1.06 | -4.39 | 14.47 | |
| Operating Cash Flow | 75.66 | 31.47 | -5.74 | -73.76 | 5.88 | |
| Operating Cash Flow Growth | 140.40% | - | - | - | - | |
| Capital Expenditures | - | -0.04 | - | -0.45 | -0.63 | |
| Sale of Property, Plant & Equipment | - | 0.1 | 0.26 | 0.89 | - | |
| Sale (Purchase) of Intangibles | - | -0.36 | -15 | - | - | |
| Investment in Securities | -92.37 | 4.43 | 10.44 | 72.33 | -79.41 | |
| Investing Cash Flow | -92.37 | 4.13 | -4.3 | 72.78 | -80.04 | |
| Long-Term Debt Issued | - | - | 19.95 | 19.54 | - | |
| Long-Term Debt Repaid | -7.5 | - | - | - | - | |
| Net Debt Issued (Repaid) | -7.5 | - | 19.95 | 19.54 | - | |
| Issuance of Common Stock | 8.1 | 1.96 | 1.05 | 2.12 | 62.68 | |
| Other Financing Activities | - | -13.61 | -2.63 | -15.12 | - | |
| Financing Cash Flow | 0.6 | -11.64 | 18.37 | 6.55 | 62.68 | |
| Net Cash Flow | -16.11 | 23.96 | 8.33 | 5.57 | -11.48 | |
| Free Cash Flow | 75.66 | 31.44 | -5.74 | -74.21 | 5.25 | |
| Free Cash Flow Growth | 140.67% | - | - | - | - | |
| Free Cash Flow Margin | 25.71% | 17.53% | -4.91% | -64.11% | 3.79% | |
| Free Cash Flow Per Share | 4.02 | 1.78 | -0.33 | -4.35 | 0.31 | |
| Cash Interest Paid | 6.57 | 7.04 | 5.85 | 2.5 | 1.5 | |
| Cash Income Tax Paid | 1.06 | 0.33 | 0.08 | - | - | |
| Levered Free Cash Flow | 74.61 | 22.99 | -25.13 | -39.83 | 10.44 | |
| Unlevered Free Cash Flow | 79.18 | 27.93 | -20.84 | -37.52 | 13.47 | |
| Change in Working Capital | -19.51 | 0.15 | 9.52 | -29.05 | 9.72 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.